MedicalResearch.com Interview with:
Dr. Manuel Serrano PhD
Tumour Suppression Group
CNIO, Melchor Fernandez Almagro 3, 28029 Madrid, Spain.
Medical Research: What are the main findings of the study?
Dr. Serrano: We investigated the contribution of rare genetic variation to human exceptional longevity (EL, individuals with ≥100 years of age) by exome-sequencing long-lived siblings in three different families where exceptional longevity clustered. We found only one gene that harbored rare variants that was likely to contribute to human longevity across all three families and this gene was the Apolipoprotein B gene (APOB). We further found that the frequency of these rare APOB variants associated with familial exceptional longevity was greater in a cohort of 206 nonfamilial cases of exceptional longevity compared to the control population, though this association did not reach statistical significance. In addition, we found rare variants in many genes within individual families that are likely to contribute to human longevity given previous studies in animals.
MedicalResearch.com: Interview with:
Dr. June Chi-Yan Lo
Research Fellow
Cognitive Neuroscience Laboratory
Duke-NUS Graduate Medical School
Singapore
MedicalResearch: What are the main findings of the study?
Dr. Lo: The Duke-NUS study examined the data of 66 older Chinese adults, from the
Singapore-Longitudinal Aging Brain Study. Participants underwent
structural MRI brain scans measuring brain volume and neuropsychological
assessments testing cognitive function every two years. Additionally,
their sleep duration was recorded through a questionnaire. Those who slept
fewer hours showed evidence of faster brain aging and decline in cognitive
performance.
MedicalResearch.com Interview with:
Richard D. Semba, MD MPH
W. Richard Green Professor of Ophthalmology
The Johns Hopkins University School of Medicine
Baltimore, MD 21287
MedicalResearch: What are the main findings of the study?
Dr. Semba: Resveratrol levels in older adults are not related to the risk of heart disease or cancer and are not related with lifespan. These findings were made in the InCHIANTI Study, a rigorously conducted study of human aging that is sponsored by the National Institute on Aging.
MedicalResearch.com Interview with:
Hanna Sanoff MD, MPH
Lineberger Comprehensive Cancer Center
Department of Medicine
University of North Carolina, Chapel Hill, NC
MedicalResearch.com: What are the main findings of the study?
Dr. Sanoff: We measured p16, a protein that increases with cellular aging, in blood cells of women receiving chemotherapy for breast cancer. We found that a standard course of chemotherapy led to an increase in p16 expression equivalent to what we have previous seen in people over the course of 10-15 years of chronological aging. This increase persisted in cancer survivors an average of three and half years after treatment.
MedicalResearch.com Interview with
Paula A. Rochon MD, MPH, FRCPC
Vice President, Research, Women's College Hospital
Senior Scientist, Women's College Research Institute
Professor, Department of Medicine
University of Toronto, Ontario Canada
MedicalResearch.com: What are the main findings of the study?
Dr. Rochon: Our main findings are that there are now more than 1800 centenarians in Ontario. Among those over 100 years of age, 60 per cent are 101 years of age or older. In addition, most centenarians are women (85 per cent), and this percentage increases to 90 per cent among those who are 105 years of age and older.
MedicalResearch.com Interview with:
Professor Andrew Steptoe, MA, DPhil, DSc, FMedSci
Director, Institute of Epidemiology and Health Care
University College London
British Heart Foundation Professor of Psychology
Department of Epidemiology and Public Health
London WC1E 6BT
MedicalResearch.com: What are the main findings of the study?
Dr. Steptoe: We are trying to understand whether positive well-being has beneficial effects as far as health and physical function is concerned. The main findings are that the risk of developing impairments in activities of daily living (things life being able to bath or shower without help) over the next few years among older people is lower in people who enjoy life more. In addition, enjoyment of life predicted less decrease in walking speed over our 8 year study period in this sample of older men and women. Of course, these associations could be due to many things: the people with greater enjoyment of life could be more affluent, have less physical illness or disability to start with, or have healthier lifestyles at the outset, and these factors could predict the changes in physical function over time. But what we found is that baseline health, economic circumstances, and lifestyle explain only part of the association between enjoyment of life and deterioration in function. So the research suggests that enjoyment of life contributes to healthier and more active old age.
MedicalResearch.com Interview with:
Dr. Laurent Azoulay
Project Leader, Lady Davis Institute
Assistant Professor, Department of Oncology, McGill University
MedicalResearch.com: What are the main findings of the study?
Dr. Azoulay: Using large population-based databases from the UK, we assembled a cohort of men newly-diagnosed with non-metastatic prostate cancer. Within this group of men, the use of statins after prostate cancer diagnosis was associated with a 24% decreased risk in cancer-related mortality. We observed duration- as well as a dose-response relationships. Furthermore, in a secondary analysis, we observed that the benefits were greater among men who used also used statins before their diagnosis, with more modest yet significant benefits among men who initiated the treatment after their diagnosis. The latter result is one of the novelties of this study, as it provides an estimate of the potential benefits of statins, if used in the adjuvant setting.
MedicalResearch.com Interview with:
Prof. Timothy Salthouse
Brown-Forman Professor of Psychology
Department of Psychology
University of Virginia
Charlottesville, VA 22904-4400
MedicalResearch.com: What prompted this work?
Prof. Salthouse: I think it is noteworthy that the research originated as an undergraduate project by Arielle Mandell. Ms. Mandell was supported by a University of Virginia Harrison Undergraduate Research Award while she was doing the research, and a report of the research served as her Distinguished Major Thesis.
The research was prompted by the observation that according to self-reports, tip-of-the-tongue experiences occur more and more frequently with increased age, and often seem to be associated with concerns about memory decline and possibly impending dementia. We wondered